BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Aratana Therapeutics Appoints Robert "Rip" Gerber to Board of Directors


10/23/2012 10:32:10 AM

KANSAS CITY, Kan. and NEW YORK, Oct. 23, 2012 /PRNewswire/ -- Aratana Therapeutics, a biopharmaceutical company developing innovative medicines for cats and dogs (companion animals), today announced it has appointed technology entrepreneur and seasoned executive Robert "Rip" Gerber as an independent Director on Aratana's Board of Directors. Mr. Gerber has a successful track record of positioning companies with new, innovative business platforms for success in rapidly growing markets.

Steven St. Peter, M.D., Chief Executive Officer of Aratana Therapeutics, stated, "We are already benefitting from Rip's keen entrepreneurial spirit, enthusiasm, and experience as an accomplished executive. His leadership roles in both private and public companies make him an asset to Aratana's Board of Directors."

Mr. Gerber stated, "I see Aratana as an industry pioneer, based upon the Company's expertise and willingness to blaze a new trail in companion animal therapeutics. I am attracted to this business platform because it not only fulfills an important medical need for pets and pet owners, but also represents a tremendous opportunity for the biotech and pharmaceutical community to increase the value of their pipelines."

Mr. Gerber is the founder, President and CEO of Locaid, a developer of "Location-as-a-Service" (LaaS), and built Locaid into world's largest LaaS platform. He has served in senior executive roles at several public and private companies. Prior to Locaid, Mr. Gerber led the restructuring, repositioning and re-branding of Intellisync, a wireless software company. Mr. Gerber was instrumental in orchestrating Intellisync's acquisition by NOKIA for $480M in 2006, where he served as Chief Marketing Officer and head of Ecommerce and Business Development. Mr. Gerber also co-founded Commtouch where he served as Chief Marketing Officer and ultimately helped take the company public in 1999. Earlier in his career, Mr. Gerber founded @once, an email marketing company that was acquired by InfoUSA. Mr. Gerber holds an MBA from Harvard Business School and a B.S. in Chemical Engineering from the University of Virginia.

About Aratana Therapeutics
Aratana Therapeutics is a company uniquely positioned to deliver high quality new medicines that address significant therapeutic needs for cats and dogs (companion animals). Aratana licenses and develops proprietary, patent-protected compounds acquired from human pharmaceutical and biotechnology companies and then develops strategies to maximize the value of the programs for the animal health market. For more information, please visit www.aratanatherapeutics.com.

For Media & Investors:
Jason Rando / Joshua Drumm, Ph.D.
Tiberend Strategic Advisors, Inc.
(212) 827-0020
jrando@tiberend.com
jdrumm@tiberend.com

SOURCE Aratana Therapeutics



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES